4 completed. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Xigen SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain XG-102, Placebo - Inflammation, Pain | Phase 3 | Completed | Xigen SA | 309 | 2015-07-01 | 2017-01-24 |
| Efficacy and Safety of XG-104 for the Treatment of Dry Eye XG-104, Placebo - Dry Eye | Phase 2 | Completed | Xigen SA | 260 | 2014-09-01 | 2016-07-18 |
| Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation XG-102, Placebo - Inflammation, Pain | Phase 3 | Completed | Xigen SA | 339 | 2014-09-01 | 2017-01-24 |
| Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers XG-102 - Inflammation | Phase 1 | Completed | Xigen SA | 24 | 2011-07-01 | 2012-04-04 |
Inflammation (3) · Cataract (2) · Pain (2) · Dry Eye Syndromes (1)
D-JNKI-1 (3)
United States (3) · Switzerland (1)
Gail Torkildsen, MD (1) · Juli Chalifour (1) · Michael Seiberling, MD (1) · Steven M Silverstein, MD (1)